Effects of aspirin on endothelial dysfunction in atherosclerosis.
Quyyumi
A A
AA
National Institutes of Health, Bethesda, Maryland 20892, USA.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D009599:Nitroprusside / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013373:Substance P / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D009599:Nitroprusside; D013373:Substance P; D000109:Acetylcholine; D001241:Aspirin